Delivery Order SPE2DB22D3401-SPE2DB24FT4BX

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,613.58 firm-fixed-price contract is for the supply of 4565179136 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The award has a completion date of July 18, 2024. This order is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $6,286.55, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a firm fixed price and a completion date of September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $2,827.52 and an ultimate completion date of June 18, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565455816 - CONTRAVE ER 8-90 MG TABLET 120S. The firm-fixed-price contract has a ceiling value of $7,785.50 and an ultimate completion date of August 15, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,028.78 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564244773 CONTRAVE ER 8-90 MG TABLET 120S. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,369.46, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order, valued at $1,823.80, is for the supply of 4,565,427,122 units of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This delivery order falls under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and is used to provide a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for CONTRAVE ER 8-90 MG TABLET 120S, a prescription pharmaceutical product. The contract has a ceiling value of $8,712.24 and a delivery completion date of August 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,397.26, is for the procurement of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of February 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The order has a ceiling value of $8,109.36 and an ultimate completion date of July 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4BX
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $5,903.08 firm-fixed-price contract is for the supply of 4,565,352,865 CONTRAVE ER 8-90 MG TABLET 120S, which are pharmaceutical products. The contract has an ultimate completion date of August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/4/24, 12:07 PM